Uploaded April 2026 | Updated September 2026, 17 hours ago

---

In this webinar, Dr. Gail Roboz discusses the Molecular International Prognostic Scoring System (IPSS-M) which is a newly developed risk stratification model for myelodysplastic syndromes (MDS) that expands on the original IPSS-R by including data on somatic oncogenic mutations across 31 gene families and weighing their impact on prognosis and outcomes.
For more webinars like this, please visit aamds.org/education/webinars
For more information on MDS, or Myelodysplastic Syndromes, please visit this site: aamds.org/diseases/mds
#MDS #myelodysplasia #aamdsif